MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA)
$3.87
+0.2000 ( +5.45% ) 159.9K
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Market Data
Open
$3.87
Previous close
$3.67
Volume
159.9K
Market cap
$84.51M
Day range
$3.66 - $3.96
52 week range
$0.82 - $5.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
8-k | 8K-related | 14 | Jun 06, 2024 |
8-k | 8K-related | 50 | Jun 04, 2024 |
8-k | 8K-related | 33 | Jun 03, 2024 |
8-k | 8K-related | 13 | May 29, 2024 |